163 related articles for article (PubMed ID: 37293256)
1. Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Deng MY; Hinz F; Maas SLN; Anil G; Sievers P; Conde-Lopez C; Lischalk J; Rauh S; Eichkorn T; Regnery S; Bauer L; Held T; Meixner E; Lang K; Hörner-Rieber J; Herfarth K; Jones D; Pfister SM; Jungk C; Unterberg A; Wick W; von Deimling A; Debus J; Sahm F; König L
Neurooncol Adv; 2023; 5(1):vdad059. PubMed ID: 37293256
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
3. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.
Hwang WL; Marciscano AE; Niemierko A; Kim DW; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Loeffler JS; Oh KS; Shih HA; Larvie M
Neuro Oncol; 2016 Jun; 18(6):863-72. PubMed ID: 26597949
[TBL] [Abstract][Full Text] [Related]
4. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
6. Recurrence pattern analysis after [
Zollner B; Ganswindt U; Maihöfer C; Corradini S; Albert NL; Schichor C; Belka C; Niyazi M
Radiat Oncol; 2018 Jun; 13(1):110. PubMed ID: 29898747
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-Interact ing-Pro t e in [TXNIP] and Transglutaminase 2 [TGM2] Expression in Meningiomas of Different Grades and the Role of Their Expression in Meningioma Recurrence and Prognosis.
Harb OA; Elsayed WS; Ismail EI; Toam MM; Ammar MG
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2299-2308. PubMed ID: 28843270
[TBL] [Abstract][Full Text] [Related]
8. The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.
Roehrkasse AM; Peterson JEG; Fung KM; Pelargos PE; Dunn IF
Front Oncol; 2022; 12():846232. PubMed ID: 35299730
[TBL] [Abstract][Full Text] [Related]
9. Genomic markers of recurrence risk in atypical meningioma following gross total resection.
Vaubel RA; Kumar R; Weiskittel TM; Jenkins S; Dasari S; Uhm JH; Lachance DH; Brown PD; Van Gompel JJ; Jenkins RB; Kipp BR; Sukov WR; Giannini C; Johnson DR; Raghunathan A
Neurooncol Adv; 2023; 5(1):vdad004. PubMed ID: 36845294
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy.
Hoffmann E; Clasen K; Frey B; Ehlers J; Behling F; Skardelly M; Bender B; Schittenhelm J; Reimold M; Tabatabai G; Zips D; Eckert F; Paulsen F
Radiat Oncol; 2021 Jun; 16(1):116. PubMed ID: 34172069
[TBL] [Abstract][Full Text] [Related]
11. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma.
Nanda A; Bir SC; Maiti TK; Konar SK; Missios S; Guthikonda B
J Neurosurg; 2017 Jan; 126(1):201-211. PubMed ID: 27058201
[TBL] [Abstract][Full Text] [Related]
12. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
Sá-Marta E; Alves JL; Rebelo O; Barbosa M
World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
[TBL] [Abstract][Full Text] [Related]
13. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
[TBL] [Abstract][Full Text] [Related]
14. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
Oya S; Kawai K; Nakatomi H; Saito N
J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
[TBL] [Abstract][Full Text] [Related]
16. Atypical meningioma. A study on recurrence and disease-specific survival.
Champeaux C; Houston D; Dunn L
Neurochirurgie; 2017 Sep; 63(4):273-281. PubMed ID: 28882609
[TBL] [Abstract][Full Text] [Related]
17. Regrowth factors of WHO grade I skull base meningiomas following incomplete resection.
Park HH; Yoo J; Oh HC; Cha YJ; Kim SH; Hong CK; Lee KS
J Neurosurg; 2022 Dec; 137(6):1656-1665. PubMed ID: 35453107
[TBL] [Abstract][Full Text] [Related]
18. The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy.
Behling F; Fodi C; Hoffmann E; Renovanz M; Skardelly M; Tabatabai G; Schittenhelm J; Honegger J; Tatagiba M
Neurosurg Rev; 2021 Aug; 44(4):2329-2336. PubMed ID: 33104905
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
Wu A; Jin MC; Meola A; Wong HN; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
[TBL] [Abstract][Full Text] [Related]
20. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.
Maas SLN; Stichel D; Hielscher T; Sievers P; Berghoff AS; Schrimpf D; Sill M; Euskirchen P; Blume C; Patel A; Dogan H; Reuss D; Dohmen H; Stein M; Reinhardt A; Suwala AK; Wefers AK; Baumgarten P; Ricklefs F; Rushing EJ; Bewerunge-Hudler M; Ketter R; Schittenhelm J; Jaunmuktane Z; Leu S; Greenway FEA; Bridges LR; Jones T; Grady C; Serrano J; Golfinos J; Sen C; Mawrin C; Jungk C; Hänggi D; Westphal M; Lamszus K; Etminan N; Jungwirth G; Herold-Mende C; Unterberg A; Harter PN; Wirsching HG; Neidert MC; Ratliff M; Platten M; Snuderl M; Aldape KD; Brandner S; Hench J; Frank S; Pfister SM; Jones DTW; Reifenberger G; Acker T; Wick W; Weller M; Preusser M; von Deimling A; Sahm F;
J Clin Oncol; 2021 Dec; 39(34):3839-3852. PubMed ID: 34618539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
